Diplopia may be first sign of giant cell arteritis
October 17th 2005A number of pathologies can be confused with giant cell arteritis, Anthony Arnold, MD, explained Monday at the American Academy of Ophthalmology annual meeting. Patients with a painful ophthalmoplegia might have an isolated cranial neuropathy, a skull-based or cavernous sinus process such as a tumor, or an inflammatory or infiltrative process, an orbital process, a brainstem process, or a vasculitic process.
Nonsurgical methods of vision correction retain a role in refractive surgery practice
October 16th 2005Corneal refractive therapy (orthokeratology) and contact lens fitting can have a complementary rather than a competitive role in a refractive surgery practice, said David Hardten, MD, at the annual meeting of the American Academy of Ophthalmology
Uncomplicated vitrectomy may cause primary open-angle glaucoma
October 16th 2005Uncomplicated vitrectomy has been implicated in the development of primary open-angle glaucoma (POAG), according to Stanley Chang, MD, who presented the Jackson Memorial Lecture Sunday at the American Academy of Ophthalmology annual meeting.
Users provide insights on lens removal with 'kinder, gentler' AquaLase
October 16th 2005Cataract surgeons experienced with the AquaLase platform of the Infiniti Vision system (Alcon Laboratories) agree that it offers multiple advantages that make it leading technology for small incision lens removal in properly selected patients.
Nonsurgical methods of vision correction retain a role in refractive surgery practice
October 16th 2005Corneal refractive therapy (orthokeratology) and contact lens fitting can have a complementary rather than a competitive role in a refractive surgery practice, said David Hardten, MD, at the annual meeting of the American Academy of Ophthalmology
Many factors have impact on treatment efficacy for amblyopia
October 16th 2005While treatment for amblyopia is effective, there is no consensus as to what treatment works best. There are a number of factors that have an impact on treatment efficacy, according to Bruce Furr, CO. He discussed these factors Sunday at the American Academy of Ophthalmology annual meeting.
Abundant evidence underlines pressure dependency of glaucoma damage
October 16th 2005While results of epidemiologic studies indicate that only one-third of glaucoma damage is attributable to excess IOP over the normal distribution, much more of glaucoma damage appears to be pressure-dependent and therefore preventable, especially in patients whose IOP is higher than average, said Paul F. Palmberg, MD, PhD.
Noteworthy colleagues, organizations honored by the AAO
October 16th 2005Recognizing significant achievements and contributions to ophthalmology, several awards were presented to physicians and organizations during opening ceremonies of the 2005 annual meeting of the American Academy of Ophthalmology (AAO).
Causes of childhood blindness changing
October 16th 2005The patterns of childhood blindness and visual impairment are changing over time, according to Clare Gilbert, MD, MSc. Dr. Gilbert described the shifts in pediatric blindness patterns resulting from the ?nurture? factors Sunday at the American Academy of Ophthalmology annual meeting.
Uncomplicated vitrectomy may cause primary open-angle glaucoma
October 16th 2005Uncomplicated vitrectomy has been implicated in the development of primary open-angle glaucoma (POAG), according to Stanley Chang, MD, who presented the Jackson Memorial Lecture Sunday at the American Academy of Ophthalmology annual meeting.
Stay ahead of curve with AAO resource center offerings
October 15th 2005Where can one preview the latest products from the American Academy of Ophthalmology (AAO), get answers to specific coding questions, talk to Washington insiders about reimbursement, personalize patient-education DVDs, get a first look at the academy's new Maintenance of Certification (MOC) products, and learn the ins and outs of acquiring and installing an electronic medical records system? There's only one place and it happens only once a year—the annual meeting, where all these resources and much more can be found at the academy resource center and technology pavilion.
Central PresbyLASIK option for selected patients
October 15th 2005Presbyopic LASIK using a multifocal ablation profile where the central zone is steepened for near and the peripheral zone targeted for distance (central PresbyLASIK) appears to be able to enhance near vision while maintaining good distance vision to offer spectacle independence to many patients and without loss of contrast sensitivity, said W. Bruce Jackson, MD, at the refractive surgery subspecialty day meeting sponsored by the International Society of Refractive Surgery of the American Academy of Ophthalmology.
Acanthamoeba keratitis potentially devastating
October 15th 2005Washington, DC—Maintaining an index of suspicion for Acanthamoeba infection in patients with keratitis is important, irrespective of a history of contact lens wear, because timely diagnosis and prompt treatment initiation are critical for a good prognosis, said John K. Dart, DM, FRCS, FRCOphth, at World Cornea Congress V.
Effective leadership skills: put to the test in emergencies
October 15th 2005I do not travel much, but recently was excited to represent my department at a special once-in-a-lifetime meeting in Asia. First, I flew to Chicago. A few hundred of us then piled into a 747 at 11 a.m., and the jet taxied out onto the runway. About to take off, we suddenly veered off to the side of the runway, the engines went dead, and fire trucks were visible heading our way.
SURGE: Sound Understanding of Real Glaucoma Efficacy
October 15th 2005Panelists at a CME symposium on Saturday evening provided an in-depth review of current information on the results of early detection and treatment with lipid therapy. Prostaglandin and prostamide drugs are widely used to lower IOP, and speakers discussed clinical data on these drugs as well as the differences between the three once-daily lipids available today.
Pegaptanib sodium data promising for DME, other retinal vascular diseases
October 15th 2005The preliminary pegaptanib sodium (Macugen, OSI/Eyetech Pharmaceuticals) exploratory phase II data indicate that the drug seems to be successful for treating diabetic macular edema (DME), according to Steven Schwartz, MD, who reported the findings of the Macugen Diabetic Retinopathy Study Group during the retina subspecialty day at the American Academy of Ophthalmology annual meeting.
Central PresbyLASIK option for selected patients
October 15th 2005Presbyopic LASIK using a multifocal ablation profile where the central zone is steepened for near and the peripheral zone targeted for distance (central PresbyLASIK) appears to be able to enhance near vision while maintaining good distance vision to offer spectacle independence to many patients and without loss of contrast sensitivity, said W. Bruce Jackson, MD, at the refractive surgery subspecialty day meeting sponsored by the International Society of Refractive Surgery of the American Academy of Ophthalmology.
Botulinum toxin considered for multitude of eye problems
October 15th 2005Botulinum toxin type A (Botox, Allergan), originally approved by the FDA as an orphan drug for the treatment of strabismus and blepharospasm, has been found to be effective for the treatment of hemifacial spasm, Meige syndrome, nystagmus, and lid retraction in Graves? disease, according to Matthew Dean Kay, MD, adjunct clinical associate professor, Nova Southeastern University, Pompano Beach, FL.
Intracorneal inlay increases depth of field to improve near vision
October 15th 2005Multicenter prospective clinical trials are ongoing to evaluate the efficacy and safety of an intracorneal inlay (Accufocus) for improving near vision, said Daniel S. Durrie, MD, at the refractive surgery subspecialty day meeting sponsored by the International Society of Refractive Surgery of the American Academy of Ophthalmology.
Refractive lens exchange surgery increases retinal detachment risk
October 15th 2005Retinal detachment is a significant risk in refractive lens exchange surgery, said Emanuel S. Rosen, MD, at the refractive surgery subspecialty day meeting sponsored by the International Society of Refractive Surgery of the American Academy of Ophthalmology.